Boston Scientific Corp. (BSX) Financials
Key financial figures for Boston Scientific Corp. (Q2 2026).
- Revenue
- $5.4B
- Net Income
- $905M
- EPS
- $0.62
- Total Assets
- $45.2B
- Operating Cash Flow
- $1.5B
Full income statement, balance sheet, and cash flow for Boston Scientific Corp. on SentiSense.